|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Riesinger, Lisa; Strobl, Claudia; Leistner, David M.; Gori, Tommaso; Akin, Ibrahim; Mehr, Michael; Kellnar, Antonia; Mahabadi, Amir A.; Bogossian, Harilaos; Block, Michael; Edelmann, Frank; Sarafoff, Nikolaus; Sibbing, Dirk; Ince, Hüseyin; Rassaf, Tienush; Mansmann, Ulrich 
ORCID: https://orcid.org/0000-0002-9955-8906; Mehilli, Julinda; Kääb, Stefan; Hausleiter, Jörg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF). Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: IJC Heart & Vessels, Bd. 35, 100810
[PDF, 569kB]
ORCID: https://orcid.org/0000-0002-9955-8906; Mehilli, Julinda; Kääb, Stefan; Hausleiter, Jörg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF). Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: IJC Heart & Vessels, Bd. 35, 100810
[PDF, 569kB]
Riesinger, Lisa; Strobl, Claudia; Leistner, David M.; Gori, Tommaso; Akin, Ibrahim; Mehr, Michael; Kellnar, Antonia; Mahabadi, Amir A.; Bogossian, Harilaos; Block, Michael; Edelmann, Frank; Sarafoff, Nikolaus; Sibbing, Dirk; Ince, Hueseyin; Rassaf, Tienush; Mansmann, Ulrich; Mehilli, Julinda; Kaeaeb, Stefan; Hausleiter, Joerg; Massberg, Steffen und Wakili, Reza
(2021):
Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF) Rationale and design of the prospective randomized parallel-group, open-label, blinded-endpoint, superiority, multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting.
In: Ijc Heart & Vasculature, Bd. 35, 100810
Gronewold, Janine; Kropp, Rene; Lehmann, Nils; Stang, Andreas; Mahabadi, Amir A.; Kaelsch, Hagen; Weimar, Christian; Dichgans, Martin; Budde, Thomas; Moebus, Susanne; Joeckel, Karl-Heinz; Erbel, Raimund und Hermann, Dirk M.
(2019):
Cardiovascular Risk and Atherosclerosis Progression in Hypertensive Persons Treated to Blood Pressure Targets.
In: Hypertension, Bd. 74, Nr. 6: S. 1436-1447